Live myositis patient video support on Dec. 21st at 2 PM ET for those living with Polymyositis, Dermatomyositis, Immune-Mediated...
Live video support on Dec. 4th at 7 PM ET for those living with Polymyositis, Dermatomyositis, Immune-Mediated Necrotizing Myopathy,...
Live myositis patient video support on Nov. 16th at 2 PM ET for those living with Polymyositis, Dermatomyositis, Immune-Mediated...
Live myositis patient video support on Thursday, Nov. 7th at 7 PM ET for those living with Polymyositis, Dermatomyositis,...
Live myositis patient video support on Oct.19th at 2 PM ET for those living with Polymyositis, Dermatomyositis, Immune-Mediated Necrotizing...
Join us on Oct. 2nd at 7 PM ET. This session is tailored to those living with Polymyositis, Dermatomyositis,...
Myositis Patient Video Support Session, September 21st at 2 PM ET. Session is tailored to those living with Polymyositis,...
Join us on September 12th at 7 PM ET. This session is tailored to those diagnosed with or suspected...
Experience of pain and fatigue in adult idiopathic inflammatory myopathies (IIM)
, , Featured, News, Video
Watch the video, "Experience of pain and fatigue in adult idiopathic inflammatory myopathies (IIM)" with Helene Alexanderson, Ph.D. with...
Myositis Patient Video Support Session, August 17th at 2 PM ET. Session is tailored to those diagnosed with or...
This session will describe the experience of pain and fatigue in adult polymyositis and dermatomyositis based on results from...
Myositis Support and Understanding (MSU) partners with the University of Pittsburgh for a new NIH-sponsored study entitled, “Myositis Patient...
Skin findings seen with myositis autoantibodies and treatment of skin in dermatomyositis
, , Dermatomyositis, Featured, News, Video
Dr. Victoria Werth joined us live online for a video education session titled, "Skin findings seen with myositis autoantibodies...
A session that covered safety and effects of exercise in recent onset and established adult and juvenile IIM. Dr....
DETERMINE - a Phase 3 trial designed to evaluate the efficacy and safety of lenabasum for the treatment of adults...
Corbus launches DETERMINE, a Phase 3 trial of lenabasum for the treatment of dermatomyositis
, , Dermatomyositis, Featured, News
New locations announced July 9, 2019. DETERMINE is a double-blind, placebo-controlled 1-year study designed to test the efficacy and...
Myositis and Cancer: Risk highest for carriers of anti-TIF1 antibody
, , Dermatomyositis, Featured, News
The research found that DM patients with the anti-transcriptional intermediary factor 1 (anti-TIF1) antibody were more than three times...
During Myositis Awareness Month, May 2018, we placed a large focus on patient education by hosting some of the...
EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
, , Featured, News
Clinical trials and studies require patient groups in clearly defined categories, but the multiple diagnostic and classification criteria used...
Dermatomyositis Patients with a Certain Type of Autoantibodies at Higher Risk of Skin Eruptions with Use of Hydroxychloroquine
, , Featured, News
In this study, the researchers set out to determine if there was a distinction between the type of autoantibodies...
Get Support!
Upcoming Events
-
Surviving the Holidays with Myositis
November 13 @ 7:00 pm - 8:30 pm EST -
Myositis Patient Video Support Session, November 16th, 2019
November 16 @ 2:00 pm - 3:30 pm EST
